Korean pharmaceutical company HLB unveiled its roadmap for adding novel anticancer treatments for three cancer types to its ...

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature ...

These results highlight CY-101’s potential to address the specific mechanisms of ACC. A collaborative approach Under the agreement, Cancer Research UK’s Centre for Drug Development (CDD) will sponsor, ...